1.
Ali MM, Ashraf SM, Mirza U, Fariduddin JM. A comparative evaluation of safety and efficacy of Rosuvastatin, Simvastatin, and Atorvastatin in patients of type 2 diabetes mellitus with dyslipidemia. Int. J. of Health Sci. [Internet]. 2022 Apr. 26 [cited 2026 Apr. 17];6(S1):7370-8. Available from: https://sciencescholar.us/journal/index.php/ijhs/article/view/6577